Change Order Review & Regulatory Impact Assessment
Elexes helps medical device manufacturers evaluate product, process, software, labeling, and supplier changes before implementation. Our experts document regulatory impact across FDA, EU MDR, TGA, Health Canada, and other frameworks, helping you avoid unnecessary submissions, reduce compliance risk, and maintain market continuity with defensible, audit-ready change decisions.
Our Change Order Review & Regulatory Impact Assessment Services
Structured regulatory review for device changes, submissions, and ongoing compliance decisions across global medical device markets.
Change Impact Assessment
Evaluate proposed changes to design, materials, manufacturing, software, labeling, or intended use to determine regulatory significance, required actions, and documentation needs across authorized markets.
Change Order Review
Review engineering and quality change orders before implementation to identify submission, notification, variation, or no-action pathways with clear regulatory rationale and auditable records.
FDA Change Assessment
Assess modifications against FDA expectations for new 510(k)s, PMA supplements, and related change guidance so teams can implement updates with confidence.
EU MDR Assessment
Determine whether device changes may be considered significant under EU MDR and MDCG guidance, including potential Notified Body involvement and documentation updates.
TGA Change Review
Analyze post-ARTG changes to establish whether notifications, variations, or new applications are required under Australian medical device regulations.
Ongoing Change Governance
Embed regulatory review into your change control workflow with standing support that keeps decisions consistent, timely, and aligned with quality system expectations.
Audit-Ready Assessments
Defensible Change Decisions Before Implementation
Change decisions should never rely on guesswork. Elexes provides structured, evidence-based assessments that help manufacturers understand whether a proposed modification affects authorized status, triggers a submission, or can proceed with documented justification. Our team reviews the technical scope of each change, applies the right regulatory framework, and delivers clear recommendations that support compliance, inspection readiness, and uninterrupted market supply.
Trusted By Manufacturers
Success Stories
See how manufacturers strengthen change control and protect market access with expert regulatory support.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for disciplined regulatory judgment and practical execution.
Deep Expertise
50+ years of collective experience across FDA, EU MDR, TGA, Health Canada, and ISO frameworks.
Global Coverage
Support for multi-market change decisions across the USA, Europe, Canada, Australia, and other regulated regions.
Proven Delivery
250+ successful projects and 200+ product types supported with structured, defensible regulatory documentation.
Flexible Support
Project-based, part-time, or embedded RAQA support that fits your internal change control workflow.
Meet The Elexes Team
Experienced regulatory specialists supporting complex device changes.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with practical, high-accountability regulatory and quality expertise across the full product lifecycle. Over the years, Elexes has become a trusted consulting partner for companies navigating approvals, quality system demands, technical documentation, and post-market obligations in highly regulated markets. Our team brings 50+ years of collective experience across FDA, EU MDR, TGA, Health Canada, ISO standards, and related global frameworks. That breadth matters when a single design, software, labeling, or manufacturing change can affect multiple market authorizations at once. Elexes works as an extension of client teams, delivering clear regulatory reasoning, audit-ready documentation, and disciplined execution that helps manufacturers move forward without creating avoidable compliance exposure.
200+ Product TypesExperience spanning diverse medical device categories and technologies.90% Audits ClearedStrong inspection and audit readiness support for regulated organizations.250+ Successful ProjectsDelivered across regulatory, quality, and market access engagements.
Frequently Asked Questions
What are the steps in the regulatory change process?
A sound regulatory change process starts with defining the proposed change and its scope, then reviewing affected design, manufacturing, labeling, software, risk, and quality records. Next comes regulatory impact assessment against applicable market rules, followed by a documented determination of required action such as notification, submission, variation, or no filing. Finally, supporting documents are updated, approvals are recorded, and implementation is controlled through change management.
What is change control in regulatory affairs?
Change control in regulatory affairs is the structured process used to evaluate whether a modification to a medical device, process, supplier, software, labeling, or intended use affects regulatory compliance or market authorization. It connects engineering and quality changes to regulatory obligations, ensuring each change is reviewed, justified, documented, and implemented only after the appropriate regulatory pathway has been determined.
When does a medical device change require a new regulatory submission?
A new submission may be required when a change could affect safety, performance, intended use, technological characteristics, manufacturing controls, software functionality, or labeling claims in a way that alters the basis of the existing authorization. The exact threshold depends on the market. FDA, EU MDR, TGA, and Health Canada each apply different criteria, so the change must be assessed against the specific framework governing that device.
What types of changes should be reviewed before implementation?
Manufacturers should review design changes, material substitutions, supplier changes, process modifications, sterilization updates, software revisions, packaging changes, labeling edits, IFU revisions, manufacturing site transfers, and intended use updates. Even changes that seem administrative can affect registrations, technical documentation, or post-market obligations. Reviewing them before implementation helps prevent unauthorized product supply and avoids corrective action later.
How is a regulatory impact assessment documented?
A regulatory impact assessment is typically documented as a formal record that describes the proposed change, identifies affected products and markets, cites the applicable regulatory criteria, evaluates significance, and states the final determination. Strong assessments also include rationale, supporting references, required follow-up actions, and approval signatures. This creates an auditable trail showing the organization evaluated the change systematically before implementation.
Can one product change affect multiple markets differently?
Yes. The same device change may trigger different obligations in different jurisdictions because each authority applies its own rules and guidance. A software update, labeling revision, or manufacturing change might require a new 510(k) analysis in the US, a significant change review under EU MDR, and a separate variation or notification assessment for TGA or Health Canada. Multi-market review is essential for globally marketed devices.
Why is change order review important for audit readiness?
Auditors and inspectors often examine whether companies assessed changes before implementation and whether the final decision was justified with evidence. Weak change review can lead to findings related to design control, document control, risk management, or unauthorized changes to marketed devices. A disciplined review process shows that regulatory, quality, and technical teams are aligned and that the organization maintains control over product lifecycle decisions.
What should manufacturers prepare before requesting a change assessment?
Manufacturers should gather the change order or engineering change request, current device description, affected drawings or specifications, risk management records, validation or verification data, labeling or IFU revisions, and a list of impacted markets. It also helps to provide the current authorization basis, such as 510(k), PMA, CE marking, ARTG inclusion, or licence details. Complete inputs allow for faster, more defensible regulatory determinations.
Still Need Change Guidance?
Talk with our regulatory experts about your next device change.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance knowledge.
